查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1383107

全球人工泪液市场预测（至2030年）

Artificial Tears Forecast till 2030
出版日期: | 出版商: Market Research Future | 英文 128 Pages | 订单完成后即时交付

价格

干眼症和眼部发炎的流行以及对无添加剂产品日益增长的偏好推动了全球人工泪液市场的成长。

区域考虑

由于干眼症的蔓延以及进入该市场的公司的存在，北美市场占据了最大的市场规模。 干眼症在美国非常普遍，影响着很大一部分人口，尤其是 50 岁以上的人口。

由于眼部疾病的流行、尖端眼药水的使用增加以及人口的快速增长，欧洲市场成为第二大市场。

亚太市场预计在研究期间将高速成长。 中国市场是亚太地区最大的市场，印度市场是亚太地区成长最快的市场。

本报告针对全球人工泪液市场进行研究和分析，提供市场动态、区域和细分市场分析、公司简介等。

目录

第 1 章执行摘要

第二章市场介绍

第三章研究方法

第 4 章市场动态

  • 摘要
  • 促进因素
    • 干眼症及眼部发炎流行
    • 人们对不含防腐剂的产品越来越感兴趣
  • 抑制因素
    • 副作用与过敏反应
  • 机会
    • 干眼症诊断的进展

第五章市场因素分析

  • 价值链分析
    • 研究与开发
    • 製造业
    • 分销和销售
    • 售后监控
  • 波特五力分析模型
  • COVID-19 对人工泪液市场的影响
    • 对供应链的影响
    • 对製造商的影响
  • 价格分析

第六章全球人工泪液市场：依类型

  • 摘要
  • 聚乙二醇
  • 丙二醇
  • 纤维素
  • 甘油
  • 其他

第七章全球人工泪液市场：以交付方式

  • 摘要
  • 眼药水
  • 软膏
  • 喷雾

第 8 章全球人工泪液市场：依应用分类

  • 摘要
  • 干眼症
  • 过敏和感染
  • 其他

第 9 章全球人工泪液市场：依通路划分

  • 摘要
  • 医院药房
  • 药局
  • 零售药局
  • 网路药局

第 10 章全球人工泪液市场：按地区

  • 摘要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 亚太地区其他地区
  • 其他领域
    • 中东
    • 非洲
    • 拉丁美洲

第十一章竞争态势

  • 主要发展与成长策略
    • 产品发布
    • 合作伙伴关係
    • 协议
    • 收购
    • 合作伙伴关係
  • 主要公司的财务矩阵
    • 销售额（2022 年）
    • 研究与发展（2022 年）

第十二章公司简介

  • JOHNSON AND JOHNSON VISION CARE
  • ALLERGAN PLC
  • ALCON PLC
  • BAUSCH & LOMB INCORPORATED
  • SANTEN, INC.
  • URSAPHARM ARZNEIMITTEL GMBH
  • ROHTO PHARMACEUTICAL CO., LTD.
  • SIMILASAN CORPORATION
  • OCUSOFT
  • NICOX

第13章附录

Product Code: MRFR/HC/10538-CR

Market Overview

The rising pervasiveness of dry eye infection and eye irritation, and the rising inclination for additive free items are driving market development.

The rising interest for additive free artificial tears inferable from the results of additives including eye disturbance, particularly for moderate or serious dry eyes is driving the artificial tears market. Moreover, the rising number of item dispatches by vital participants is expanding item separation and consequently driving market development. For example, In January 2022, Alcon (Switzerland) sent off Systane complete additive free oil eye drops in the European market. Similarly, in October 2019, Allergan, Inc. (Auxiliary of AbbVie, US) sent off the Invigorate Relieva grease eye drop product offering, an extension of the Revive portfolio. The product offering included Revive Relieva PF (additive free) multidose.

Moreover, expanding item dispatches for additive free items is driving the artificial tears market. Besides, propels in bundling plan and conveyance systems for additive free eye drops to forestall tainting are further driving the market for artificial tears market. Hence, expanding inclination for additive free items is driving the market development.

Market Segmentation

Based on type, the Artificial Tears Market is divided into segments such as cellulose, glycerin, propylene glycol, and polyethylene glycol. The market is separated into eye drops, ointments, and sprays based on the mechanism of delivery.

The dry eye condition, allergies, infections, and other conditions are categorized under the application sector of the artificial tears market. Hospital pharmacies, drug stores, retail pharmacies, and internet pharmacies are all part of the distribution system.

Regional Insights

The North America artificial tears market represented the largest market owing to the of the great commonness of dry eye sickness, the presence of market vital participants, and the developing interest for contact focal points in the region Dry eye illness is exceptionally far reaching in the US, influencing a huge level of the populace, especially those beyond 50 years old.

Europe artificial tears market represents the second-largest market owing to the great pervasiveness of ophthalmic issues, expanding utilization of cutting-edge eye drops, and a quickly flooding maturing populace. further, UK artificial tears market was credited to hold the biggest market share, and the France artificial tears market is supposed to quickest developing market in the European region.

The Asia-Pacific artificial tears market is supposed to develop at a fast rate during the review period. This is because of the solid likely persistent populace, rising consciousness of visual illnesses, and expanding medical services consumption in the Asia-Pacific region. Besides, China artificial tears market is supposed to hold the biggest market offer, and India artificial tears market is normal quickest developing market in the Asia-Pacific region.

Major Players

Key Companies in the worldwide Artificial Tears Market are Johnson and Johnson Vision Care (US), Allergan plc (Ireland), Alcon Plc (Switzerland), Bausch & Lomb Incorporated (Canada), Santen, Inc (Japan), URSAPHARM Arzneimittel GmbH (Germany), ROHTO Pharmaceutical CO., LTD (Japan), Similasan Corporation (US), Ocusoft (US), and Nicox (France).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY
  • 2.2 RESEARCH OBJECTIVE
  • 2.3 MARKET STRUCTURE
  • 2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING PREVALENCE OF DRY EYE DISEASE AND EYE INFLAMMATION
    • 4.2.2 RISING PREFERENCE FOR PRESERVATIVE-FREE PRODUCTS
  • 4.3 RESTRAINTS
    • 4.3.1 SIDE-EFFECTS AND ALLERGIC REACTIONS
  • 4.4 OPPORTUNITIES
    • 4.4.1 ADVANCEMENT IN DIAGNOSTICS FOR DRY EYE DISEASE

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE ARTIFICIAL TEARS MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON MANUFACTURERS
  • 5.4 PRICING ANALYSIS

6 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 POLYETHYLENE GLYCOL
  • 6.3 PROPYLENE GLYCOL
  • 6.4 CELLULOSE
  • 6.5 GLYCERIN
  • 6.6 OTHERS

7 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE

  • 7.1 OVERVIEW
  • 7.2 EYE DROPS
  • 7.3 OINTMENTS
  • 7.4 SPRAYS

8 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION

  • 8.1 OVERVIEW
  • 8.2 DRY EYE SYNDROME
  • 8.3 ALLERGIES AND INFECTIONS
  • 8.4 OTHERS

9 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL

  • 9.1 OVERVIEW
  • 9.2 HOSPITAL PHARMACIES
  • 9.3 DRUG STORES
  • 9.4 RETAIL PHARMACIES
  • 9.5 ONLINE PHARMACIES

10 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 US
    • 10.2.2 CANADA
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 UK
    • 10.3.3 FRANCE
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 JAPAN
    • 10.4.2 CHINA
    • 10.4.3 INDIA
    • 10.4.4 AUSTRALIA
    • 10.4.5 SOUTH KOREA
    • 10.4.6 REST OF ASIA-PACIFIC
  • 10.5 REST OF THE WORLD
    • 10.5.1 MIDDLE EAST
    • 10.5.2 AFRICA
    • 10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

  • 11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.7.1 PRODUCT LAUNCH
    • 11.7.2 COLLABORATION
    • 11.7.3 AGREEMENT
    • 11.7.4 ACQUISITION
    • 11.7.5 PARTNERSHIP
  • 11.8 MAJOR PLAYERS FINANCIAL MATRIX
    • 11.8.1 SALES (USD BILLION), 2022
    • 11.8.2 R&D (USD BILLION), 2022

12 COMPANY PROFILES

  • 12.1 JOHNSON AND JOHNSON VISION CARE
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS OFFERED
    • 12.1.4 KEY DEVELOPMENTS
    • 12.1.5 SWOT ANALYSIS
    • 12.1.6 KEY STRATEGIES
  • 12.2 ALLERGAN PLC
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS OFFERED
    • 12.2.4 KEY DEVELOPMENTS
    • 12.2.5 SWOT ANALYSIS
    • 12.2.6 KEY STRATEGIES
  • 12.3 ALCON PLC
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCTS OFFERED
    • 12.3.4 KEY DEVELOPMENTS
    • 12.3.5 SWOT ANALYSIS
    • 12.3.6 KEY STRATEGIES
  • 12.4 BAUSCH & LOMB INCORPORATED
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS OFFERED
    • 12.4.4 KEY DEVELOPMENTS
    • 12.4.5 SWOT ANALYSIS
    • 12.4.6 KEY STRATEGIES
  • 12.5 SANTEN, INC.
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS OFFERED
    • 12.5.4 KEY DEVELOPMENTS
    • 12.5.5 SWOT ANALYSIS
    • 12.5.6 KEY STRATEGIES
  • 12.6 URSAPHARM ARZNEIMITTEL GMBH
    • 12.6.1 COMPANY OVERVIEW
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS OFFERED
    • 12.6.4 KEY DEVELOPMENTS
    • 12.6.5 KEY STRATEGIES
  • 12.7 ROHTO PHARMACEUTICAL CO., LTD.
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS OFFERED
    • 12.7.4 KEY DEVELOPMENTS
    • 12.7.5 KEY STRATEGIES
  • 12.8 SIMILASAN CORPORATION
    • 12.8.1 COMPANY OVERVIEWS
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS OFFERED
    • 12.8.4 KEY DEVELOPMENTS
    • 12.8.5 KEY STRATEGIES
  • 12.9 OCUSOFT
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 PRODUCTS OFFERED
    • 12.9.4 KEY DEVELOPMENTS
    • 12.9.5 KEY STRATEGIES
  • 12.10 NICOX
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 PRODUCTS OFFERED
    • 12.10.4 KEY DEVELOPMENTS
    • 12.10.5 KEY STRATEGIES

13 APPENDIX

  • 13.1 REFERENCES
  • 13.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 4 GLOBAL ARTIFICIAL TEARS MARKET, FOR POLYETHYLENE GLYCOL, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 5 GLOBAL ARTIFICIAL TEARS MARKET, FOR PROPYLENE GLYCOL, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 6 GLOBAL ARTIFICIAL TEARS MARKET, FOR CELLULOSE, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 7 GLOBAL ARTIFICIAL TEARS MARKET, FOR GLYCERIN, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 8 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 9 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 10 GLOBAL ARTIFICIAL TEARS MARKET, FOR EYE DROPS, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 11 GLOBAL ARTIFICIAL TEARS MARKET, FOR OINTMENTS, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 12 GLOBAL ARTIFICIAL TEARS MARKET, FOR SPRAYS, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 13 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 14 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRY EYE SYNDROME, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 15 GLOBAL ARTIFICIAL TEARS MARKET, FOR ALLERGIES AND INFECTIONS, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 16 GLOBAL ARTIFICIAL TEARS MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 17 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 18 GLOBAL ARTIFICIAL TEARS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 19 GLOBAL ARTIFICIAL TEARS MARKET, FOR DRUG STORES, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 20 GLOBAL ARTIFICIAL TEARS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 21 GLOBAL ARTIFICIAL TEARS MARKET, FOR ONLINE PHARMACIES, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 22 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, 2019-2030 (USD BILLION)
  • TABLE 23 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
  • TABLE 24 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 25 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 26 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 27 NORTH AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 28 US: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 29 US: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 30 US: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 31 US: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 32 CANADA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 33 CANADA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 34 CANADA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 35 CANADA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 36 EUROPE: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
  • TABLE 37 EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 38 EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 39 EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 40 EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 41 GERMANY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 42 GERMANY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 43 GERMANY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 44 GERMANY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 45 UK: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 46 UK: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 47 UK: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 48 UK: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 49 FRANCE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 50 FRANCE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 51 FRANCE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 52 FRANCE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 53 ITALY: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 54 ITALY: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 55 ITALY: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 56 ITALY: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 57 SPAIN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 58 SPAIN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 59 SPAIN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 60 SPAIN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 61 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 62 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 63 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 64 REST OF EUROPE: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 65 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
  • TABLE 66 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 67 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 68 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 69 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 70 JAPAN: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 71 JAPAN: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 72 JAPAN: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 73 JAPAN: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 74 CHINA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 75 CHINA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 76 CHINA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 77 CHINA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 78 INDIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 79 INDIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 80 INDIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 81 INDIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 82 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 83 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 84 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 85 AUSTRALIA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 86 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 87 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 88 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 89 SOUTH KOREA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 90 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 91 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 92 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 93 REST OF ASIA-PACIFIC: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 94 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
  • TABLE 95 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 96 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 97 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 98 REST OF THE WORLD: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 99 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 100 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 101 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 102 MIDDLE EAST: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 103 AFRICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 104 AFRICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 105 AFRICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 106 AFRICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 107 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY TYPE, 2019-2030 (USD BILLION)
  • TABLE 108 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2019-2030 (USD BILLION)
  • TABLE 109 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY APPLICATION, 2019-2030 (USD BILLION)
  • TABLE 110 LATIN AMERICA: ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD BILLION)
  • TABLE 111 MAJOR PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET
  • TABLE 2 MOST ACTIVE PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET
  • TABLE 3 PRODUCT LAUNCH
  • TABLE 4 COLLABORATION
  • TABLE 5 AGREEMENT
  • TABLE 6 ACQUISITION
  • TABLE 7 PARTNERSHIP
  • TABLE 8 JOHNSON AND JOHNSON VISION: PRODUCTS OFFERED
  • TABLE 9 ALLERGAN PLC: PRODUCTS OFFERED
  • TABLE 10 ALLERGAN PLC: KEY DEVELOPMENTS
  • TABLE 11 ALCON PLC: PRODUCTS OFFERED
  • TABLE 12 ALCON PLC: KEY DEVELOPMENTS
  • TABLE 13 BAUSCH & LOMB INCORPORATED: PRODUCTS OFFERED
  • TABLE 14 BAUSCH & LOMB INCORPORATED: KEY DEVELOPMENTS
  • TABLE 15 SANTEN PHARMACEUTICALS INC.: PRODUCTS OFFERED
  • TABLE 16 URSAPHARM ARZNEIMITTEL GMBH: PRODUCTS OFFERED
  • TABLE 17 URSAPHARM ARZNEIMITTEL GMBH: KEY DEVELOPMENTS
  • TABLE 18 ROHTO PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 19 ROHTO PHARMACEUTICAL CO., LTD.: KEY DEVELOPMENTS
  • TABLE 20 SIMILASAN CORPORATION: PRODUCTS OFFERED
  • TABLE 21 OCUSOFT: PRODUCTS OFFERED
  • TABLE 22 OCUSOFT: KEY DEVELOPMENTS
  • TABLE 23 NICOX: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL ARTIFICIAL TEARS MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: PROTEIN ENGINEERING MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ARTIFICIAL TEARS MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: ARTIFICIAL TEARS MARKET
  • FIGURE 9 GLOBAL ARTIFICIAL TEARS MARKET, BY TYPE, 2022 & 2030 (USD BILLION)
  • FIGURE 10 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY TYPE (%), 2022
  • FIGURE 11 GLOBAL ARTIFICIAL TEARS MARKET, BY DELIVERY MODE, 2022 & 2030 (USD BILLION)
  • FIGURE 12 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY DELIVERY MODE (%), 2022
  • FIGURE 13 GLOBAL ARTIFICIAL TEARS MARKET, BY APPLICATION, 2022 & 2030 (USD BILLION)
  • FIGURE 14 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY APPLICATION (%), 2022
  • FIGURE 15 GLOBAL ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (USD BILLION)
  • FIGURE 16 GLOBAL ARTIFICIAL TEARS MARKET SHARE, BY DISTRIBUTION CHANNEL (%), 2022
  • FIGURE 17 GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, 2022 & 2030 (USD BILLION)
  • FIGURE 18 GLOBAL ARTIFICIAL TEARS MARKET SHARE (%), BY REGION, 2022
  • FIGURE 19 NORTH AMERICA: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 20 EUROPE ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 21 ASIA-PACIFIC: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 22 REST OF THE WORLD: ARTIFICIAL TEARS MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 24 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ARTIFICIAL TEARS MARKET
  • FIGURE 25 GLOBAL ARTIFICIAL TEARS MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 26 SALES, 2021
  • FIGURE 27 R&D, 2021
  • FIGURE 28 JOHNSON AND JOHNSON VISION: SWOT ANALYSIS
  • FIGURE 29 ALLERGAN PLC: SWOT ANALYSIS
  • FIGURE 30 ALCON PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 31 ALCON PLC: SWOT ANALYSIS
  • FIGURE 32 BAUSCH & LOMB INCORPORATED: SWOT ANALYSIS
  • FIGURE 33 SANTEN PHARMACEUTICALS INC.: FINANCIAL OVERVIEW
  • FIGURE 34 SANTEN PHARMACEUTICALS INC.: SWOT ANALYSIS
  • FIGURE 35 NICOX: FINANCIAL OVERVIEW SNAPSHOT